{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:07:21Z","timestamp":1791986841018,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.abd.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T09:00:12Z","timestamp":1667552412000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dermatological manifestations of hematologic neoplasms. Part I: secondary specific skin lesions"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3943-3036","authenticated-orcid":false,"given":"Patricia Karla de","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-3198","authenticated-orcid":false,"given":"Rafael Oliveira","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-5531","authenticated-orcid":false,"given":"Let\u00edcia Siqueira","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-8586","authenticated-orcid":false,"given":"Mariana Dias","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2022.06.002_bib0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review","volume":"21","author":"Malei","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.blre.2017.07.003","article-title":"The skin as a window to the blood: cutaneous manifestations of myeloid malignancies","volume":"31","author":"Li","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.abd.2022.06.002_bib0015","first-page":"27","article-title":"Leukemia cutis - epidemiology, clinical presentation, and differential diagnoses","volume":"10","author":"Wagner","year":"2012","journal-title":"J Deut Dermatol Ges"},{"key":"10.1016\/j.abd.2022.06.002_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jfma.2020.04.025","article-title":"Leukemia cutis in a medical center in southern Taiwan: a retrospective study of 42 patients","volume":"120","author":"Chang","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.abd.2022.06.002_bib0025","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.ad.2016.02.015","article-title":"Leucemia cutis. Serie de 17 casos y revisi\u00f3n de la literatura","volume":"107","author":"Mart\u00ednez-Lebor\u00e1ns","year":"2016","journal-title":"Actas Dermo-Sifiliogr"},{"key":"10.1016\/j.abd.2022.06.002_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11912-020-00919-6","article-title":"Diagnostic and therapeutic considerations for extramedullary leukemia","volume":"22","author":"Bakst","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.abd.2022.06.002_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jdcr.2018.10.019","article-title":"Rare case of leukemia cutis presenting as erythroderma in a patient with acute myeloid leukemia","volume":"5","author":"Donaldson","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.abd.2022.06.002_bib0040","first-page":"326","article-title":"Clinical characterization of leukemia cutis presentation","volume":"104","author":"Haidari","year":"2019","journal-title":"Cutis"},{"key":"10.1016\/j.abd.2022.06.002_bib0045","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1123","article-title":"Leukaemia cutis: clinical features and outcomes of 56 patients","volume":"102","author":"Yook","year":"2022","journal-title":"Acta Dermato-Venereol"},{"key":"10.1016\/j.abd.2022.06.002_bib0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/abd1806-4841.20186327","article-title":"Clinical and pathological features of myeloid leukemia cutis","volume":"93","author":"Li","year":"2018","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00277-020-04349-z","article-title":"Skin changes in hairy cell leukemia","volume":"100","author":"Robak","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.abd.2022.06.002_bib0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2016.02.020","article-title":"Cutaneous manifestations in leukemia patients","volume":"43","author":"Grunwald","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.abd.2022.06.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.abd.2022.06.002_bib0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","article-title":"Leukemia cutis","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Am J Clinl Pathol"},{"key":"10.1016\/j.abd.2022.06.002_bib0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ijd.15629","article-title":"Chronic lymphocytic leukemia and the skin: implications for the dermatologist","volume":"61","author":"Fried","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12185-020-02978-8","article-title":"Cutaneous manifestations of B-cell chronic lymphocytic leukemia","volume":"112","author":"Morozova","year":"2020","journal-title":"Intl J Hematol"},{"key":"10.1016\/j.abd.2022.06.002_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2340\/00015555-1458","article-title":"Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia","volume":"93","author":"Hurley","year":"2013","journal-title":"Acta Dermato-Venereol"},{"key":"10.1016\/j.abd.2022.06.002_bib0090","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/pde.13864","article-title":"Pediatric leukemia cutis: a case series","volume":"36","author":"Andriescu","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5114\/ada.2021.107923","article-title":"Leukaemia cutis for clinicians, a literature review","volume":"38","author":"Osmola","year":"2021","journal-title":"Adv Dermatol Allergol"},{"key":"10.1016\/j.abd.2022.06.002_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000497210","article-title":"Myeloid Sarcoma","volume":"42","author":"Magdy","year":"2019","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.abd.2022.06.002_bib0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamadermatol.2019.0052","article-title":"Association of leukemia cutis with survival in acute myeloid leukemia","volume":"155","author":"Wang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.seminoncol.2016.02.017","article-title":"Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders","volume":"43","author":"Bhutani","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.abd.2022.06.002_bib0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mjd.2003.180","article-title":"The spectrum of cutaneous disease in multiple myeloma","volume":"48","author":"Bayer-Garner","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5045\/br.2017.52.4.324","article-title":"A case of primary plasma cell leukemia exhibiting hemophagocytic plasma cells relapsed with multiple cutaneous plasmacytoma","volume":"52","author":"Hwang","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.abd.2022.06.002_bib0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ajcp\/aqaa122","article-title":"Cutaneous involvement in plasma cell myeloma","volume":"155","author":"Panse","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.abd.2022.06.002_bib0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2017.08.054","article-title":"Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: a case series from Korea","volume":"78","author":"Woo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.hoc.2018.08.005","article-title":"Cutaneous involvement of hematologic malignancies","volume":"33","author":"Kaddis","year":"2019","journal-title":"Hematol\/Oncol Clin N Am"},{"key":"10.1016\/j.abd.2022.06.002_bib0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjd.13582","article-title":"Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell line","volume":"173","author":"Lee","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jaad.2012.02.033","article-title":"World Health Organization\u2013European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution","volume":"67","author":"Park","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1346-8138.2010.01049.x","article-title":"Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008","volume":"38","author":"Fujita","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0560.2006.00460.x","article-title":"The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification","volume":"33","author":"Yasukawa","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2022.06.002_bib0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/modpathol.3880411","article-title":"Cutaneous presentation of follicular lymphomas","volume":"14","author":"Franco","year":"2001","journal-title":"Mod Patholol"},{"key":"10.1016\/j.abd.2022.06.002_bib0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/ajd.12307","article-title":"Cutaneous manifestations of peripheral T-cell lymphoma, not otherwise specified: a case series highlighting the diagnostic challenges for this heterogeneous group","volume":"56","author":"Wallett","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0170","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.abd.2022.06.002_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2005.11.1055","article-title":"Cutaneous Hodgkin\u2019s disease","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0180","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/1097-0142(197011)26:5<1135::AID-CNCR2820260525>3.0.CO;2-J","article-title":"The mode of spread of Hodgkin\u2019s disease to the skin","volume":"26","author":"Benninghoff","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.abd.2022.06.002_bib0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cup.13798","article-title":"Secondary cutaneous involvement by direct extension in high\u2010grade B\u2010cell lymphomas","volume":"48","author":"Subtil","year":"2021","journal-title":"J Cutan Patholol"},{"key":"10.1016\/j.abd.2022.06.002_bib0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(09)70351-1","article-title":"Common misdiagnoses in lymphomas and avoidance strategies","volume":"11","author":"Chan","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.abd.2022.06.002_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjd.13904","article-title":"Cutaneous involvement from systemic lymphoma","volume":"173","author":"Rickaby","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2022.06.002_bib0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11864-016-0401-9","article-title":"Checkpoint inhibitors and other immune therapies for Hodgkin and non-Hodgkin lymphoma","volume":"17","author":"Matsuki","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.abd.2022.06.002_bib0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hon.2844","article-title":"Optimizing CAR T cell therapy in lymphoma","volume":"39","author":"Qualls","year":"2021","journal-title":"Hematol Oncol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622002380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622002380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:41:27Z","timestamp":1759794087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622002380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0365059622002380"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2022.06.002","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatological manifestations of hematologic neoplasms. Part I: secondary specific skin lesions","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}